Brice Sid
Impact in
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
Papers in
-
- Metabolism, Diabetes, and Cancer 4
- Coenzyme Q10 studies and effects 4
-
- Liver Disease Diagnosis and Treatment 3
- Co-authors
- Pedro Buc Calderón (14 shared papers)Julien Verrax (11 shared papers)Christophe Glorieux (9 shared papers)Nicolas Dejeans (6 shared papers)Raphaël Beck (3 shared papers)Georges Bellon (4 shared papers)Hervé Sartelet (4 shared papers)Stéphane Dedieu (4 shared papers)
In The Last Decade
Brice Sid
21 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 93
- Toxicology 64
- Cancer Research 186
- Molecular Biology 656
- Hepatology 68
- Cell Biology 139
Countries citing papers authored by Brice Sid
This map shows the geographic impact of Brice Sid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brice Sid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brice Sid more than expected).
Fields of papers citing papers by Brice Sid
This network shows the impact of papers produced by Brice Sid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brice Sid. The network helps show where Brice Sid may publish in the future.
Co-authors
The 25 scholars most cited alongside Brice Sid, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 122 | |
| 2 | 2013 | 117 | |
| 3 | 2004 | 88 | |
| 4 | 2013 | 87 | |
| 5 | 2012 | 80 | |
| 6 | 2008 | 64 | |
| 7 | 2011 | 57 | |
| 8 | 2014 | 56 | |
| 9 | 2010 | 54 | |
| 10 | 2006 | 48 | |
| 11 | 2011 | 48 | |
| 12 | 2014 | 43 | |
| 13 | 2014 | 40 | |
| 14 | 2017 | 34 | |
| 15 | 2006 | 30 | |
| 16 | 2016 | 30 | |
| 17 | 2008 | 29 | |
| 18 | 2014 | 25 | |
| 19 | 2012 | 24 | |
| 20 | 2013 | 22 |
About Brice Sid
Brice Sid is a scholar working on Molecular Biology, Epidemiology, Hepatology, Cancer Research and Surgery, having authored 21 papers that have together received 1.1k indexed citations. Recurring topics across this work include Metabolism, Diabetes, and Cancer (4 papers), Coenzyme Q10 studies and effects (4 papers), Protease and Inhibitor Mechanisms (4 papers), Pancreatic function and diabetes (3 papers), Liver physiology and pathology (3 papers), Vitamin C and Antioxidants Research (3 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Liver Disease Diagnosis and Treatment (3 papers). The work is most often cited by research in Toxicology (64 citations), Cancer Research (186 citations), Molecular Biology (656 citations), Hepatology (68 citations) and Cell Biology (139 citations). Brice Sid has collaborated with scholars based in Belgium, Chile and France. Frequent co-authors include Pedro Buc Calderón, Julien Verrax, Christophe Glorieux, Nicolas Dejeans, Raphaël Beck, Georges Bellon, Hervé Sartelet, Stéphane Dedieu, Laurent Martiny and Mustapha Najimi. Their work appears in journals such as Biochemical Pharmacology, Biochemical and Biophysical Research Communications, The International Journal of Biochemistry & Cell Biology, The Journal of Physiology and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.